Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:PRAX News 30 December 2025 - 14 January 2026

Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

New York, January 14, 2026, 14:54 EST — During regular session Shares of Praxis Precision Medicines jumped roughly 8% on Wednesday, bucking the weaker trend in the broader market. By mid-afternoon, the Nasdaq-listed biotech was trading at $303.23, up $22.40. The move came after Praxis announced late Tuesday it hired epilepsy expert Dr. Orrin Devinsky for a new head of…
14 January 2026
····
Praxis Precision stock rises as $575 million share sale clears at $260

Praxis Precision stock rises as $575 million share sale clears at $260

NEW YORK, Jan 7, 2026, 12:02 PM EST — Regular session Praxis Precision Medicines shares rose about 6% on Wednesday after the biotech priced a $575 million public offering overnight, even as the deal came at a discount to the prior close. GlobeNewswire The Boston-based company late Tuesday set the offering at $260 per share for 2.212 million shares, and…
7 January 2026
·····
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

NEW YORK, December 30, 2025, 14:54 ET — Regular session Shares of Praxis Precision Medicines Inc (NASDAQ: PRAX) slipped about 3% on Tuesday, giving back part of a sharp rally sparked by an FDA regulatory boost for its lead essential tremor program. The stock was down 3% at $295.50 as of 2:39 p.m. ET, after opening at $304.00 and trading…
30 December 2025
·····
Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target

Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target

NEW YORK, December 30, 2025, 05:21 ET — Premarket Praxis Precision Medicines Inc shares rose 13.25% on Monday to close at $304.58, after the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for its essential tremor candidate ulixacaltamide, a filing showed. The stock opened at $317.72 and traded between $298 and $317.72, and was down about 1% in after-hours…
30 December 2025
·····
Praxis Precision Medicines (PRAX) stock jumps 13% after FDA breakthrough designation for tremor drug

Praxis Precision Medicines (PRAX) stock jumps 13% after FDA breakthrough designation for tremor drug

NEW YORK, December 30, 2025, 00:52 ET — Market closed. Praxis Precision Medicines shares climbed about 13% in Monday’s session, last trading at $304.58, after the company said U.S. regulators granted Breakthrough Therapy Designation for its experimental essential tremor treatment. The stock swung between $318.08 and $275.00 during the day. The designation, known as BTD, is an FDA pathway meant…
30 December 2025
·····

Stock Market Today

  • Sensex, Nifty Open Lower Ahead of Budget; Rupee Hits Record Low
    January 28, 2026, 11:33 PM EST. India's benchmark indices, the S&P BSE Sensex and NSE Nifty 50, opened lower on Thursday, snapping a two-day rally linked to a recent India-EU trade deal. The Sensex fell 275 points to 82,069.68, while Nifty lost 48 points to 25,294.75 by 9:25 a.m. The rupee declined to its all-time low against the dollar, adding pressure. Larsen & Toubro and Tata Steel led sector gains, but key stocks like Maruti Suzuki and Titan slipped. According to Dr. VK Vijayakumar of Geojit Investments, the recent 300-point Nifty rally was a temporary response as investors await Sunday's budget announcement. Foreign institutional investors remain net sellers unless the budget offers incentives, potentially weighing on the market. Midcaps and smallcaps showed modest gains, while volatility edged higher. Positive triggers such as a possible US-India trade deal could still boost market sentiment.
Go toTop